APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metagenomics Sequencing Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Metagenomics Sequencing Services Market Outlook and Growth Opportunities 2026

16 January 2026217 pages

Choose your research edition.

Industry ResearchMetagenomics Sequencing Services Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Metagenomics Sequencing Services Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Metagenomics Sequencing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metagenomics Sequencing Services Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Metagenomics Sequencing Services Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Metagenomics Sequencing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Metagenomics Sequencing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Metagenomics Sequencing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metagenomics Sequencing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Metagenomics Sequencing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Metagenomics Sequencing Services market include Novogene, CD Genomics, BGI, MR DNA, Macrogen Europe, Norgen Biotek Corp., Psomagen, LC Sciences and IMGM, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Metagenomics Sequencing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metagenomics Sequencing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metagenomics Sequencing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Metagenomics Sequencing Services market.

Metagenomics Sequencing Services Segment by Company

Novogene

CD Genomics

BGI

MR DNA

Macrogen Europe

Norgen Biotek Corp.

Psomagen

LC Sciences

IMGM

CosmosID

MicrobesNG

Synbio Technologies

NCIMB

Discovery Life Sciences

Nucleome

Creative Biolabs

Yaazh Xenomics

LGC Biosearch Technologies

AGTC Genomics

LabMal

GenomeScan

Metagenomics Sequencing Services Segment by Type

Amplicon Sequencing

Shotgun Sequencing

Others

Metagenomics Sequencing Services Segment by Application

Environmental Samples

Wastewater Analysis

Food Testing

Human Microbiome Sample

Others

Metagenomics Sequencing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Metagenomics Sequencing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Metagenomics Sequencing Services key companies, revenue, market share, and recent developments.

3. To split the Metagenomics Sequencing Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Metagenomics Sequencing Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Metagenomics Sequencing Services significant trends, drivers, influence factors in global and regions.

6. To analyze Metagenomics Sequencing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metagenomics Sequencing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metagenomics Sequencing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metagenomics Sequencing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Metagenomics Sequencing Services industry.

Chapter 3: Detailed analysis of Metagenomics Sequencing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Metagenomics Sequencing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Metagenomics Sequencing Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Metagenomics Sequencing Services Industry Trends Table 2. Metagenomics Sequencing Services Industry Drivers Table 3. Metagenomics Sequencing Services Industry Opportunities and Challenges Table 4. Metagenomics Sequencing Services Industry Restraints Table 5. Global Metagenomics Sequencing Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Metagenomics Sequencing Services Revenue Share by Company (2021-2026) Table 7. Global Metagenomics Sequencing Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Metagenomics Sequencing Services Key Company Manufacturing Base & Headquarters Table 9. Global Metagenomics Sequencing Services Company, Product Type & Application Table 10. Global Metagenomics Sequencing Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Metagenomics Sequencing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Amplicon Sequencing Table 15. Significant Companies of Shotgun Sequencing Table 16. Significant Companies of Others Table 17. Global Metagenomics Sequencing Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Metagenomics Sequencing Services Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Metagenomics Sequencing Services Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Metagenomics Sequencing Services Sales Value Share by Type (2021-2026) Table 21. Global Metagenomics Sequencing Services Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Environmental Samples Table 23. Significant Companies of Wastewater Analysis Table 24. Significant Companies of Food Testing Table 25. Significant Companies of Human Microbiome Sample Table 26. Significant Companies of Others Table 27. Global Metagenomics Sequencing Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Metagenomics Sequencing Services Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Metagenomics Sequencing Services Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Metagenomics Sequencing Services Sales Value Share by Application (2021-2026) Table 31. Global Metagenomics Sequencing Services Sales Value Share by Application (2027-2032) Table 32. Global Metagenomics Sequencing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Metagenomics Sequencing Services Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Metagenomics Sequencing Services Sales Value Share by Region (2021-2026) Table 35. Global Metagenomics Sequencing Services Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Metagenomics Sequencing Services Sales Value Share by Region (2027-2032) Table 37. Global Metagenomics Sequencing Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Metagenomics Sequencing Services Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Metagenomics Sequencing Services Sales Value Market Share by Country (2021-2026) Table 40. Global Metagenomics Sequencing Services Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Metagenomics Sequencing Services Sales Value Market Share by Country (2027-2032) Table 42. Novogene Company Information Table 43. Novogene Business Overview Table 44. Novogene Metagenomics Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Novogene Metagenomics Sequencing Services Product Portfolio Table 46. Novogene Recent Development Table 47. CD Genomics Company Information Table 48. CD Genomics Business Overview Table 49. CD Genomics Metagenomics Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. CD Genomics Metagenomics Sequencing Services Product Portfolio Table 51. CD Genomics Recent Development Table 52. BGI Company Information Table 53. BGI Business Overview Table 54. BGI Metagenomics Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. BGI Metagenomics Sequencing Services Product Portfolio Table 56. BGI Recent Development Table 57. MR DNA Company Information Table 58. MR DNA Business Overview Table 59. MR DNA Metagenomics Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. MR DNA Metagenomics Sequencing Services Product Portfolio Table 61. MR DNA Recent Development Table 62. Macrogen Europe Company Information Table 63. Macrogen Europe Business Overview Table 64. Macrogen Europe Metagenomics Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Macrogen Europe Metagenomics Sequencing Services Product Portfolio Table 66. Macrogen Europe Recent Development Table 67. Norgen Biotek Corp. Company Information Table 68. Norgen Biotek Corp. Business Overview Table 69. Norgen Biotek Corp. Metagenomics Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Norgen Biotek Corp. Metagenomics Sequencing Services Product Portfolio Table 71. Norgen Biotek Corp. Recent Development Table 72. Psomagen Company Information Table 73. Psomagen Business Overview Table 74. Psomagen Metagenomics Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Psomagen Metagenomics Sequencing Services Product Portfolio Table 76. Psomagen Recent Development Table 77. LC Sciences Company Information Table 78. LC Sciences Business Overview Table 79. LC Sciences Metagenomics Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. LC Sciences Metagenomics Sequencing Services Product Portfolio Table 81. LC Sciences Recent Development Table 82. IMGM Company Information Table 83. IMGM Business Overview Table 84. IMGM Metagenomics Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. IMGM Metagenomics Sequencing Services Product Portfolio Table 86. IMGM Recent Development Table 87. CosmosID Company Information Table 88. CosmosID Business Overview Table 89. CosmosID Metagenomics Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. CosmosID Metagenomics Sequencing Services Product Portfolio Table 91. CosmosID Recent Development Table 92. MicrobesNG Company Information Table 93. MicrobesNG Business Overview Table 94. MicrobesNG Metagenomics Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. MicrobesNG Metagenomics Sequencing Services Product Portfolio Table 96. MicrobesNG Recent Development Table 97. Synbio Technologies Company Information Table 98. Synbio Technologies Business Overview Table 99. Synbio Technologies Metagenomics Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Synbio Technologies Metagenomics Sequencing Services Product Portfolio Table 101. Synbio Technologies Recent Development Table 102. NCIMB Company Information Table 103. NCIMB Business Overview Table 104. NCIMB Metagenomics Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. NCIMB Metagenomics Sequencing Services Product Portfolio Table 106. NCIMB Recent Development Table 107. Discovery Life Sciences Company Information Table 108. Discovery Life Sciences Business Overview Table 109. Discovery Life Sciences Metagenomics Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Discovery Life Sciences Metagenomics Sequencing Services Product Portfolio Table 111. Discovery Life Sciences Recent Development Table 112. Nucleome Company Information Table 113. Nucleome Business Overview Table 114. Nucleome Metagenomics Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Nucleome Metagenomics Sequencing Services Product Portfolio Table 116. Nucleome Recent Development Table 117. Creative Biolabs Company Information Table 118. Creative Biolabs Business Overview Table 119. Creative Biolabs Metagenomics Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Creative Biolabs Metagenomics Sequencing Services Product Portfolio Table 121. Creative Biolabs Recent Development Table 122. Yaazh Xenomics Company Information Table 123. Yaazh Xenomics Business Overview Table 124. Yaazh Xenomics Metagenomics Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Yaazh Xenomics Metagenomics Sequencing Services Product Portfolio Table 126. Yaazh Xenomics Recent Development Table 127. LGC Biosearch Technologies Company Information Table 128. LGC Biosearch Technologies Business Overview Table 129. LGC Biosearch Technologies Metagenomics Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. LGC Biosearch Technologies Metagenomics Sequencing Services Product Portfolio Table 131. LGC Biosearch Technologies Recent Development Table 132. AGTC Genomics Company Information Table 133. AGTC Genomics Business Overview Table 134. AGTC Genomics Metagenomics Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. AGTC Genomics Metagenomics Sequencing Services Product Portfolio Table 136. AGTC Genomics Recent Development Table 137. LabMal Company Information Table 138. LabMal Business Overview Table 139. LabMal Metagenomics Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. LabMal Metagenomics Sequencing Services Product Portfolio Table 141. LabMal Recent Development Table 142. GenomeScan Company Information Table 143. GenomeScan Business Overview Table 144. GenomeScan Metagenomics Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. GenomeScan Metagenomics Sequencing Services Product Portfolio Table 146. GenomeScan Recent Development Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Metagenomics Sequencing Services Product Image Figure 2. Global Metagenomics Sequencing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metagenomics Sequencing Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Metagenomics Sequencing Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Amplicon Sequencing Image Figure 8. Shotgun Sequencing Image Figure 9. Others Image Figure 10. Global Metagenomics Sequencing Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Metagenomics Sequencing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Metagenomics Sequencing Services Sales Value Share by Type (2021-2032) Figure 13. Environmental Samples Image Figure 14. Wastewater Analysis Image Figure 15. Food Testing Image Figure 16. Human Microbiome Sample Image Figure 17. Others Image Figure 18. Global Metagenomics Sequencing Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Metagenomics Sequencing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Metagenomics Sequencing Services Sales Value Share by Application (2021-2032) Figure 21. Global Metagenomics Sequencing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Metagenomics Sequencing Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Metagenomics Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 24. North America Metagenomics Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Metagenomics Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Metagenomics Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Metagenomics Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Metagenomics Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Metagenomics Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 30. South America Metagenomics Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Metagenomics Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Metagenomics Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Amplicon Sequencing
  • Shotgun Sequencing
  • Others
Applications
  • Environmental Samples
  • Wastewater Analysis
  • Food Testing
  • Human Microbiome Sample
  • Others
Companies covered
  • Novogene
  • CD Genomics
  • BGI
  • MR DNA
  • Macrogen Europe
  • Norgen Biotek Corp.
  • Psomagen
  • LC Sciences
  • IMGM
  • CosmosID
  • MicrobesNG
  • Synbio Technologies
  • NCIMB
  • Discovery Life Sciences
  • Nucleome
  • Creative Biolabs
  • Yaazh Xenomics
  • LGC Biosearch Technologies
  • AGTC Genomics
  • LabMal
  • GenomeScan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Metagenomics Sequencing Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Metagenomics Sequencing Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Metagenomics Sequencing Services Market Dynamics
  1. 2.1 Metagenomics Sequencing Services Industry Trends
  2. 2.2 Metagenomics Sequencing Services Industry Drivers
  3. 2.3 Metagenomics Sequencing Services Industry Opportunities and Challenges
  4. 2.4 Metagenomics Sequencing Services Industry Restraints
3 Metagenomics Sequencing Services Market by Company
  1. 3.1 Global Metagenomics Sequencing Services Company Revenue Ranking in 2025
  2. 3.2 Global Metagenomics Sequencing Services Revenue by Company (2021-2026)
  3. 3.3 Global Metagenomics Sequencing Services Company Ranking (2024-2026)
  4. 3.4 Global Metagenomics Sequencing Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Metagenomics Sequencing Services Company Product Type and Application
  6. 3.6 Global Metagenomics Sequencing Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Metagenomics Sequencing Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Metagenomics Sequencing Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Metagenomics Sequencing Services Market by Type
  1. 4.1 Metagenomics Sequencing Services Type Introduction
  2. 4.1.1 Amplicon Sequencing
  3. 4.1.2 Shotgun Sequencing
  4. 4.1.3 Others
  5. 4.2 Global Metagenomics Sequencing Services Sales Value by Type
  6. 4.2.1 Global Metagenomics Sequencing Services Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Metagenomics Sequencing Services Sales Value by Type (2021-2032)
  8. 4.2.3 Global Metagenomics Sequencing Services Sales Value Share by Type (2021-2032)
5 Metagenomics Sequencing Services Market by Application
  1. 5.1 Metagenomics Sequencing Services Application Introduction
  2. 5.1.1 Environmental Samples
  3. 5.1.2 Wastewater Analysis
  4. 5.1.3 Food Testing
  5. 5.1.4 Human Microbiome Sample
  6. 5.1.5 Others
  7. 5.2 Global Metagenomics Sequencing Services Sales Value by Application
  8. 5.2.1 Global Metagenomics Sequencing Services Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Metagenomics Sequencing Services Sales Value by Application (2021-2032)
  10. 5.2.3 Global Metagenomics Sequencing Services Sales Value Share by Application (2021-2032)
6 Metagenomics Sequencing Services Regional Value Analysis
  1. 6.1 Global Metagenomics Sequencing Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Metagenomics Sequencing Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Metagenomics Sequencing Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Metagenomics Sequencing Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Metagenomics Sequencing Services Sales Value (2021-2032)
  7. 6.3.2 North America Metagenomics Sequencing Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Metagenomics Sequencing Services Sales Value (2021-2032)
  10. 6.4.2 Europe Metagenomics Sequencing Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Metagenomics Sequencing Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Metagenomics Sequencing Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Metagenomics Sequencing Services Sales Value (2021-2032)
  16. 6.6.2 South America Metagenomics Sequencing Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Metagenomics Sequencing Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Metagenomics Sequencing Services Sales Value Share by Country, 2025 VS 2032
7 Metagenomics Sequencing Services Country-level Value Analysis
  1. 7.1 Global Metagenomics Sequencing Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Metagenomics Sequencing Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Metagenomics Sequencing Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Metagenomics Sequencing Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Metagenomics Sequencing Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Metagenomics Sequencing Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Metagenomics Sequencing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novogene
  2. 8.1.1 Novogene Company Information
  3. 8.1.2 Novogene Business Overview
  4. 8.1.3 Novogene Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novogene Metagenomics Sequencing Services Product Portfolio
  6. 8.1.5 Novogene Recent Developments
  7. 8.2 CD Genomics
  8. 8.2.1 CD Genomics Company Information
  9. 8.2.2 CD Genomics Business Overview
  10. 8.2.3 CD Genomics Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CD Genomics Metagenomics Sequencing Services Product Portfolio
  12. 8.2.5 CD Genomics Recent Developments
  13. 8.3 BGI
  14. 8.3.1 BGI Company Information
  15. 8.3.2 BGI Business Overview
  16. 8.3.3 BGI Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BGI Metagenomics Sequencing Services Product Portfolio
  18. 8.3.5 BGI Recent Developments
  19. 8.4 MR DNA
  20. 8.4.1 MR DNA Company Information
  21. 8.4.2 MR DNA Business Overview
  22. 8.4.3 MR DNA Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MR DNA Metagenomics Sequencing Services Product Portfolio
  24. 8.4.5 MR DNA Recent Developments
  25. 8.5 Macrogen Europe
  26. 8.5.1 Macrogen Europe Company Information
  27. 8.5.2 Macrogen Europe Business Overview
  28. 8.5.3 Macrogen Europe Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Macrogen Europe Metagenomics Sequencing Services Product Portfolio
  30. 8.5.5 Macrogen Europe Recent Developments
  31. 8.6 Norgen Biotek Corp.
  32. 8.6.1 Norgen Biotek Corp. Company Information
  33. 8.6.2 Norgen Biotek Corp. Business Overview
  34. 8.6.3 Norgen Biotek Corp. Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Norgen Biotek Corp. Metagenomics Sequencing Services Product Portfolio
  36. 8.6.5 Norgen Biotek Corp. Recent Developments
  37. 8.7 Psomagen
  38. 8.7.1 Psomagen Company Information
  39. 8.7.2 Psomagen Business Overview
  40. 8.7.3 Psomagen Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Psomagen Metagenomics Sequencing Services Product Portfolio
  42. 8.7.5 Psomagen Recent Developments
  43. 8.8 LC Sciences
  44. 8.8.1 LC Sciences Company Information
  45. 8.8.2 LC Sciences Business Overview
  46. 8.8.3 LC Sciences Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LC Sciences Metagenomics Sequencing Services Product Portfolio
  48. 8.8.5 LC Sciences Recent Developments
  49. 8.9 IMGM
  50. 8.9.1 IMGM Company Information
  51. 8.9.2 IMGM Business Overview
  52. 8.9.3 IMGM Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 IMGM Metagenomics Sequencing Services Product Portfolio
  54. 8.9.5 IMGM Recent Developments
  55. 8.10 CosmosID
  56. 8.10.1 CosmosID Company Information
  57. 8.10.2 CosmosID Business Overview
  58. 8.10.3 CosmosID Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CosmosID Metagenomics Sequencing Services Product Portfolio
  60. 8.10.5 CosmosID Recent Developments
  61. 8.11 MicrobesNG
  62. 8.11.1 MicrobesNG Company Information
  63. 8.11.2 MicrobesNG Business Overview
  64. 8.11.3 MicrobesNG Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MicrobesNG Metagenomics Sequencing Services Product Portfolio
  66. 8.11.5 MicrobesNG Recent Developments
  67. 8.12 Synbio Technologies
  68. 8.12.1 Synbio Technologies Company Information
  69. 8.12.2 Synbio Technologies Business Overview
  70. 8.12.3 Synbio Technologies Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Synbio Technologies Metagenomics Sequencing Services Product Portfolio
  72. 8.12.5 Synbio Technologies Recent Developments
  73. 8.13 NCIMB
  74. 8.13.1 NCIMB Company Information
  75. 8.13.2 NCIMB Business Overview
  76. 8.13.3 NCIMB Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 NCIMB Metagenomics Sequencing Services Product Portfolio
  78. 8.13.5 NCIMB Recent Developments
  79. 8.14 Discovery Life Sciences
  80. 8.14.1 Discovery Life Sciences Company Information
  81. 8.14.2 Discovery Life Sciences Business Overview
  82. 8.14.3 Discovery Life Sciences Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Discovery Life Sciences Metagenomics Sequencing Services Product Portfolio
  84. 8.14.5 Discovery Life Sciences Recent Developments
  85. 8.15 Nucleome
  86. 8.15.1 Nucleome Company Information
  87. 8.15.2 Nucleome Business Overview
  88. 8.15.3 Nucleome Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Nucleome Metagenomics Sequencing Services Product Portfolio
  90. 8.15.5 Nucleome Recent Developments
  91. 8.16 Creative Biolabs
  92. 8.16.1 Creative Biolabs Company Information
  93. 8.16.2 Creative Biolabs Business Overview
  94. 8.16.3 Creative Biolabs Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Creative Biolabs Metagenomics Sequencing Services Product Portfolio
  96. 8.16.5 Creative Biolabs Recent Developments
  97. 8.17 Yaazh Xenomics
  98. 8.17.1 Yaazh Xenomics Company Information
  99. 8.17.2 Yaazh Xenomics Business Overview
  100. 8.17.3 Yaazh Xenomics Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Yaazh Xenomics Metagenomics Sequencing Services Product Portfolio
  102. 8.17.5 Yaazh Xenomics Recent Developments
  103. 8.18 LGC Biosearch Technologies
  104. 8.18.1 LGC Biosearch Technologies Company Information
  105. 8.18.2 LGC Biosearch Technologies Business Overview
  106. 8.18.3 LGC Biosearch Technologies Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 LGC Biosearch Technologies Metagenomics Sequencing Services Product Portfolio
  108. 8.18.5 LGC Biosearch Technologies Recent Developments
  109. 8.19 AGTC Genomics
  110. 8.19.1 AGTC Genomics Company Information
  111. 8.19.2 AGTC Genomics Business Overview
  112. 8.19.3 AGTC Genomics Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 AGTC Genomics Metagenomics Sequencing Services Product Portfolio
  114. 8.19.5 AGTC Genomics Recent Developments
  115. 8.20 LabMal
  116. 8.20.1 LabMal Company Information
  117. 8.20.2 LabMal Business Overview
  118. 8.20.3 LabMal Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 LabMal Metagenomics Sequencing Services Product Portfolio
  120. 8.20.5 LabMal Recent Developments
  121. 8.21 GenomeScan
  122. 8.21.1 GenomeScan Company Information
  123. 8.21.2 GenomeScan Business Overview
  124. 8.21.3 GenomeScan Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 GenomeScan Metagenomics Sequencing Services Product Portfolio
  126. 8.21.5 GenomeScan Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst